Home LiteratureArticle Details

PMID: 17284038 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide.

Journal of the American Chemical Society ·Vol. 129 ·No. 9 ·2007-03-07 ·Pages 2456-7

Bernal F, Tyler AF, Korsmeyer SJ, Walensky LD, Verdine GL

Abstract

暂无摘要

MeSH Terms

Amino Acid Sequence Binding Sites Cell-Penetrating Peptides/chemistry,genetics,metabolism Circular Dichroism DNA-Binding Proteins/chemistry,genetics,metabolism Fluorenes/chemistry Humans Molecular Sequence Data Oncogenes Peptides/chemistry,genetics,metabolism Promoter Regions, Genetic Spectrometry, Fluorescence Tumor Cells, Cultured Tumor Suppressor Protein p53/chemistry,genetics,metabolism

Chemicals

Cell-Penetrating Peptides DNA-Binding Proteins Fluorenes Peptides SAH-p53-8 peptide Tumor Suppressor Protein p53

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Bernal Federico

Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.

Tyler Andrew F

Korsmeyer Stanley J

Walensky Loren D

Verdine Gregory L

References (29)

29 references, click to expand

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3077-80 PMID: 10077639
p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.
Oncogene. 1999 Mar 18;18(11):1921-34 PMID: 10208414
Activation of an MDM2-specific caspase by p53 in the absence of apoptosis.
J Biol Chem. 1999 May 21;274(21):15271-7 PMID: 10329737
A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines.
J Mol Biol. 2000 May 26;299(1):245-53 PMID: 10860736
Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53.
J Med Chem. 2000 Aug 24;43(17):3205-8 PMID: 10966738
A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation.
Science. 2001 Jun 8;292(5523):1910-5 PMID: 11397945
Isolation and structure elucidation of Chlorofusin, a novel p53-MDM2 antagonist from a Fusarium sp.
J Am Chem Soc. 2001 Jan 31;123(4):554-60 PMID: 11456567
Inhibiting the p53-MDM2 interaction: an important target for cancer therapy.
Nat Rev Cancer. 2003 Feb;3(2):102-9 PMID: 12563309
Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
Science. 2003 Dec 12;302(5652):1972-5 PMID: 14671306
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Science. 2004 Feb 6;303(5659):844-8 PMID: 14704432
Helical beta-peptide inhibitors of the p53-hDM2 interaction.
J Am Chem Soc. 2004 Aug 11;126(31):9468-9 PMID: 15291512
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix.
Science. 2004 Sep 3;305(5689):1466-70 PMID: 15353804
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
Cell. 1992 Jun 26;69(7):1237-45 PMID: 1535557
Use of a retroinverso p53 peptide as an inhibitor of MDM2.
J Am Chem Soc. 2004 Dec 22;126(50):16288-9 PMID: 15600307
Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells.
J Med Chem. 2005 Feb 24;48(4):909-12 PMID: 15715460
Solution structure of a beta-peptide ligand for hDM2.
J Am Chem Soc. 2005 Mar 30;127(12):4118-9 PMID: 15783163
The P53 pathway: what questions remain to be explored?
Cell Death Differ. 2006 Jun;13(6):1027-36 PMID: 16557269
Crystallographic analysis of an 8-mer p53 peptide analogue complexed with MDM2.
J Am Chem Soc. 2006 Aug 30;128(34):11000-1 PMID: 16925398
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.
Nature. 1991 Jul 25;352(6333):345-7 PMID: 1852210
p53 mutations in human cancers.
Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
Participation of p53 protein in the cellular response to DNA damage.
Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PMID: 1933891
Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.
Genes Dev. 1994 May 15;8(10):1235-46 PMID: 7926727
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
Cell. 1994 Mar 25;76(6):1013-23 PMID: 8137420
WAF1, a potential mediator of p53 tumor suppression.
Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.
Oncogene. 1993 Dec;8(12):3411-6 PMID: 8247544
The p53-mdm-2 autoregulatory feedback loop.
Genes Dev. 1993 Jul;7(7A):1126-32 PMID: 8319905
mdm2 expression is induced by wild type p53 activity.
EMBO J. 1993 Feb;12(2):461-8 PMID: 8440237
Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.
Science. 1996 Nov 8;274(5289):948-53 PMID: 8875929
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.
FEBS Lett. 1997 Dec 22;420(1):25-7 PMID: 9450543

Article Info

Journal

Journal of the American Chemical Society

Abbr.

J Am Chem Soc

ISSN

0002-7863

DOI

10.1021/ja0693587

Published

2007-03-07

Epub

2007-00-07

Pages

2456-7

Language

English

Region

United States

NLM ID

7503056

PMCID

PMC6333086

Subset

Grants

NCI NIH HHS · F32 CA 103510 · United States

NHLBI NIH HHS · KO8 HL 074049 · United States

NHLBI NIH HHS · K08 HL074049 · United States

NCI NIH HHS · K22 CA128886 · United States

Wellcome Trust · United Kingdom

NCI NIH HHS · F32 CA103510 · United States

Corrections

ErratumIn

External Links

PubMed source DOI: 10.1021/ja0693587 PMC Full Text View journal details

Analysis Services

Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide.

Contact

WeChat Official Account